CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,635,000 | +20.6% | 1,500,000 | +50.0% | 1.78% | +33.9% |
| Q2 2021 | $6,330,000 | -47.5% | 1,000,000 | -31.0% | 1.33% | +37.6% |
| Q2 2020 | $12,067,000 | +1025.7% | 1,448,604 | +936.8% | 0.96% | +761.6% |
| Q1 2020 | $1,072,000 | -89.6% | 139,718 | -85.4% | 0.11% | -89.0% |
| Q1 2019 | $10,310,000 | – | 959,077 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
| Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
| Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
| RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
| Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
| Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
| WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |